| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.16 | 0.0004 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.089 | 0.06 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.09 | 0.06 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.068 | 0.1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.076 | 0.2 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.063 | 0.2 |